Drugs to treat diabetes, heart disease and blood cancers among those affected by price negotiations
The Biden administration says Medicare recipients will save about $1.5 billion on out-of-pocket costs for medications to treat diabetes, heart disease, types of arthritis and other ailments under new prices negotiated with drug companies that will take effect in 2026. The savings range from 79% for Januvia, used to manage diabetes, to 38% for Imbruvica, … Read more
